{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T19:39:19Z","timestamp":1775936359733,"version":"3.50.1"},"reference-count":46,"publisher":"CMA Joule Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.9778\/cmajo.20200107","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T18:06:12Z","timestamp":1604685972000},"page":"E706-E714","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness of antithrombotic agents for atrial fibrillation in older adults at risk for falls: a mathematical modelling study"],"prefix":"10.9778","volume":"8","author":[{"given":"Eric K.C.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Belza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.J.","family":"Naimark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon E.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harindra C.","family":"Wijeysundera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"382","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"2021052814062125000_8.4.E706.1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.012004"},{"key":"2021052814062125000_8.4.E706.2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420130036007"},{"key":"2021052814062125000_8.4.E706.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140263.20897.42"},{"key":"2021052814062125000_8.4.E706.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000199613.38911.b2"},{"key":"2021052814062125000_8.4.E706.5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5853\/jos.2016.00864","article-title":"Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update","volume":"19","author":"An","year":"2017","journal-title":"J Stroke"},{"key":"2021052814062125000_8.4.E706.6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/000313481408001014","article-title":"Incidence of intracranial hemorrhage and outcomes after ground-level falls in geriatric trauma patients taking preinjury anticoagulants and antiplatelet agents","volume":"80","author":"Reddy","year":"2014","journal-title":"Am Surg"},{"key":"2021052814062125000_8.4.E706.7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MAJ.0000000000000349","article-title":"Physician\u2019s fear of anticoagulant therapy in nonvalvular atrial fibrillation","volume":"348","author":"Sen","year":"2014","journal-title":"Am J Med Sci"},{"key":"2021052814062125000_8.4.E706.8","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.7.677"},{"key":"2021052814062125000_8.4.E706.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5058"},{"key":"2021052814062125000_8.4.E706.10","doi-asserted-by":"crossref","unstructured":"Wells G Coyle D Cameron C (2012) Safety, effectiveness, and cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation: CADTH therapeutic review (Canadian Agency for Drugs and Technologies in Health, Ottawa).","DOI":"10.1016\/j.jval.2013.01.009"},{"key":"2021052814062125000_8.4.E706.11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/M15-2531","article-title":"Use of decision models in the development of evidence-based clinical preventive services recommendations: methods of the U.S. Preventive Services Task Force","volume":"165","author":"Owens","year":"2016","journal-title":"Ann Intern Med"},{"key":"2021052814062125000_8.4.E706.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864"},{"key":"2021052814062125000_8.4.E706.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.06.019"},{"key":"2021052814062125000_8.4.E706.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812293192604"},{"key":"2021052814062125000_8.4.E706.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60986-6"},{"key":"2021052814062125000_8.4.E706.16","unstructured":"(2017) Guidelines for the economic evaluation of health technologies: Canada (Canadian Agency for Drugs and Technologies in Health, Ottawa), 4th ed."},{"key":"2021052814062125000_8.4.E706.17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40273-015-0337-0","article-title":"Myths and misconceptions of within-cycle correction: a guide for modelers and decision makers","volume":"34","author":"Elbasha","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"2021052814062125000_8.4.E706.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1049"},{"key":"2021052814062125000_8.4.E706.19","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.19.5.604"},{"key":"2021052814062125000_8.4.E706.20","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.593087"},{"key":"2021052814062125000_8.4.E706.21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","article-title":"2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"2021052814062125000_8.4.E706.22","doi-asserted-by":"crossref","unstructured":"Pandey H Paulden M McCabe C (2018) Theoretical models of the cost-effectiveness threshold, value assessment, and health care system sustainability (Institute of Health Economics, Edmonton).","DOI":"10.1016\/j.jval.2018.09.2173"},{"key":"2021052814062125000_8.4.E706.23","first-page":"473","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations","volume":"146","author":"Laupacis","year":"1992","journal-title":"CMAJ"},{"key":"2021052814062125000_8.4.E706.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.10.036"},{"key":"2021052814062125000_8.4.E706.25","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309901"},{"key":"2021052814062125000_8.4.E706.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"2021052814062125000_8.4.E706.27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.034","article-title":"Modest association between the discharge modified Rankin Scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis","volume":"24","author":"Asuzu","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2021052814062125000_8.4.E706.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04085.x"},{"key":"2021052814062125000_8.4.E706.29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.02.011","article-title":"Prestroke CHA2DS2-VASc score and severity of acute stroke in patients with atrial fibrillation: findings from RAF Study","volume":"26","author":"Acciarresi","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2021052814062125000_8.4.E706.30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.conctc.2017.01.008","article-title":"The distribution of the modified Rankin Scale scores change according to eligibility criteria in acute ischemic stroke trials: a consideration for sample size calculations when using ordinal regression analysis","volume":"5","author":"Olavarr\u00eda","year":"2017","journal-title":"Contemp Clin Trials Commun"},{"key":"2021052814062125000_8.4.E706.31","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.10.946"},{"key":"2021052814062125000_8.4.E706.32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq250"},{"key":"2021052814062125000_8.4.E706.33","doi-asserted-by":"publisher","DOI":"10.1159\/000121343"},{"key":"2021052814062125000_8.4.E706.34","unstructured":"(2009) The economic burden of injury in Canada (SMARTRISK, Toronto)."},{"key":"2021052814062125000_8.4.E706.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000920"},{"key":"2021052814062125000_8.4.E706.36","unstructured":"About long-term care in Ontario: facts and figures (Ontario Long Term Care Association, Toronto) Available: www.oltca.com\/oltca\/OLTCA\/Public\/LongTermCare\/FactsFigures.aspx . accessed 2020 Jan. 9."},{"key":"2021052814062125000_8.4.E706.37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/2396987316683780","article-title":"Dependency and health utilities in stroke: data to inform cost-effectiveness analyses","volume":"2","author":"Ali","year":"2017","journal-title":"Eur Stroke J"},{"key":"2021052814062125000_8.4.E706.38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12877-016-0354-7","article-title":"Cost-utility of medication withdrawal in older fallers: results from the improving medication prescribing to reduce risk of FALLs (IMPROveFALL) trial","volume":"16","author":"Polinder","year":"2016","journal-title":"BMC Geriatr"},{"key":"2021052814062125000_8.4.E706.39","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200006000-00004"},{"key":"2021052814062125000_8.4.E706.40","unstructured":"(2020) Life tables, Canada, provinces and territories, 1980\/1982 to 2016\/2018 (Statistics Canada, Ottawa) Availablehttps:\/\/www150.statcan.gc.ca\/n1\/pub\/84-537-x\/84-537-x2019002-eng.htm . accessed 2020 Oct. 30."},{"key":"2021052814062125000_8.4.E706.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03989.x"},{"key":"2021052814062125000_8.4.E706.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"2021052814062125000_8.4.E706.43","unstructured":"Ontario Ministry of Health and Long-Term Care Drugs funded by Ontario Drug Benefit (ODB) Program: e-formulary (Queen\u2019s Printer for Ontario, Toronto) updated 2019 Nov 29, version 2.8. Available: www.formulary.health.gov.on.ca\/formulary\/ . accessed 2020 Jan. 9."},{"key":"2021052814062125000_8.4.E706.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.09.008"},{"key":"2021052814062125000_8.4.E706.45","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/jgs.15982","article-title":"Apixaban concentrations with lower than recommended dosing in older adults with atrial fibrillation","volume":"67","author":"Sukumar","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2021052814062125000_8.4.E706.46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.1.77"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20200107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T21:51:14Z","timestamp":1622238674000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20200107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,11,6]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.9778\/cmajo.20200107"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20200107","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}